Abstract
Linked statistics from hospital records and death certificates were used to study the incidence of and mortality from motor neuron disease in a defined English population. The incidence of motor neuron disease, measured as first-admission rates for the disease, was studied from 1963 to 1985 and death certificates for the patients admitted to hospital were obtained to the end of 1990. The average annual first-admission rate for motor neuron disease was 2.1/100,000 men (95% confidence interval (CI) 1.9 to 2.4) and 1.7/100,000 women (95% CI 1.5 to 1.9). First-admission rates increased with age and peaked in the age range 65-84 years. Motor neuron disease was recorded on the death certificate for 86% of patients who died while they had the disease and there was no appreciable change over time in the recording of motor neuron disease as the underlying cause of death. The admission and mortality data derive from different sources, hospital statistical abstracts and death certificates respectively, but trends over time in the two data sets were similar. There was an increase in mortality during the period covered by the study, as there has been in mortality from motor neuron disease nationally, and the increase in mortality in the Oxford region was accompanied by an increase in first-admission rates. It is concluded that the increase in mortality from motor neuron disease probably occurred as a result of an increase in the diagnosed incidence of the disease rather than changes in death certification practice.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Buckley J., Warlow C., Smith P., Hilton-Jones D., Irvine S., Tew J. R. Motor neuron disease in England and Wales, 1959-1979. J Neurol Neurosurg Psychiatry. 1983 Mar;46(3):197–205. doi: 10.1136/jnnp.46.3.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Durrleman S., Alperovitch A. Increasing trend of ALS in France and elsewhere: are the changes real? Neurology. 1989 Jun;39(6):768–773. doi: 10.1212/wnl.39.6.768. [DOI] [PubMed] [Google Scholar]
- Elian M., Dean G. The changing mortality from motor neurone disease and multiple sclerosis in England and Wales and the Republic of Ireland. Neuroepidemiology. 1992;11(4-6):236–243. doi: 10.1159/000110936. [DOI] [PubMed] [Google Scholar]
- Flaten T. P. Rising mortality from motoneuron disease. Lancet. 1989 May 6;1(8645):1018–1019. doi: 10.1016/s0140-6736(89)92661-5. [DOI] [PubMed] [Google Scholar]
- Lilienfeld D. E., Chan E., Ehland J., Godbold J., Landrigan P. J., Marsh G., Perl D. P. Rising mortality from motoneuron disease in the USA, 1962-84. Lancet. 1989 Apr 1;1(8640):710–713. doi: 10.1016/s0140-6736(89)92218-6. [DOI] [PubMed] [Google Scholar]
- Neilson S., Robinson I., Hunter M. Longitudinal Gompertzian analysis of ALS mortality in England and Wales, 1963-1989: estimates of susceptibility in the general population. Mech Ageing Dev. 1992 Jun;64(1-2):201–216. doi: 10.1016/0047-6374(92)90107-o. [DOI] [PubMed] [Google Scholar]
- Swash M., Leigh N. Criteria for diagnosis of familial amyotrophic lateral sclerosis. European FALS Collaborative Group. Neuromuscul Disord. 1992;2(1):7–9. doi: 10.1016/0960-8966(92)90020-7. [DOI] [PubMed] [Google Scholar]